ProText Mobility logo

ProText Mobility(OTC) TXTM

Market Cap$79.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+2,900%
5 Year+246%
1 Year+246%
1 Month+154%
$0.01
+0.00%
+0.00Today
ProText Mobility last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-19
ProText Mobility stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+16.88%USD 0.012026-10-12
1 month+153.52%USD 0.002026-09-18
3 month+116.87%USD 0.002026-07-21
Year to date+164.71%USD 0.002025-12-31
1 year+246.15%USD 0.002025-10-17
3 year+1,185.71%USD 0.002023-10-20
5 year+246.15%USD 0.002021-10-20
Since inception+2,900%USD 0.002017-01-03

ProText Mobility Financials at a Glance

Market Cap

$79.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$500.51K

EPS (TTM)

$0.00

P/E Ratio

90.00

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$0.01

Volume

10,574,606

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

TXTM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProText Mobility

ProText Mobility, Inc. is a biotechnology company focused on developing pharmaceutical botanical medicines using highly-bioavailable plant extracts. Based in Fort Lauderdale, Florida, the company aims to innovate within the healthcare sector.

Products and Services
  • Development of pharmaceutical botanical medicines
  • Formulation of medicines with plant extracts
  • Focus on highly-bioavailable products
Growth Outlook
  • Market demand for botanical medicines is increasing
  • Potential for expansion in the healthcare sector
  • Innovative product formulations may attract new customers
Financial Highlights
  • Recent quarterly net income of -$15,452
  • Trailing twelve months (TTM) price-to-earnings ratio of 91
  • Market capitalization of approximately $80 million
ProText Mobility, Inc. operates in a growing market with increasing interest in botanical medicines. The company's focus on innovative formulations positions it well to capitalize on this trend. Despite recent financial challenges, the potential for growth remains significant, particularly as consumer preferences shift towards natural and plant-based products. The company's market capitalization reflects its standing in the biotechnology sector, and the TTM price-to-earnings ratio indicates investor interest in future profitability. Overall, ProText Mobility, Inc. presents an intriguing opportunity for those interested in the biotechnology landscape.
AI Generated • Oct 20, 2026

Industry

Biotechnology

Employees

30

CEO

Plooy Du Dylon

Headquarters

Fort Lauderdale, FL 33301, US

TXTM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

-0.33%

Return on Assets

0.00%

Earnings Yield

1.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$79.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.79B

Volume

10.57M

Avg. Volume

9.29M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$56.98K

EBITDA

-$56.98K

Operating Cash Flow

-$53.77K

Capital Expenditure

$0.00

Free Cash Flow

-$53.77K

Cash & ST Invst.

$0.00

Total Debt

$69.68K

ProText Mobility Performance Analysis

ProText Mobility annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
ProText Mobility sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
ProText Mobility annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
ProText Mobility sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31-100.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$79.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.64M

N/A

Employees

30

N/A

Net Income

-$15.45K

+16.6%

EBITDA

-$13.76K

+20.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$0.00

N/A

Total Debt

$69.68K

+212.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$69.68K

+212.7%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$10.81K

+36.8%

Operating Cash Flow

-$10.81K

+36.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DVHGFDevonian Health Group, Inc.
$4.94+91900.76%
GNCPGNCC Capital, Inc.
$0.00+0.00%
ENVBEnveric Biosciences, Inc.
$1.44+3.60%
PTIXProtagenic Therapeutics, Inc.
$0.75+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$97.55-1.11%
SPCXSpace Exploration Technologies
$147.79-0.11%
CRWVCoreWeave
$62.13+1.65%
INTCIntel
$91.69-0.37%

Questions About TXTM

What is the current price of ProText Mobility?

ProText Mobility is trading at $0.01 per share.

What is the 52-week range for ProText Mobility?

Over the past 52 weeks, ProText Mobility has traded between $0.00 and $0.01.

How much debt does ProText Mobility have?

As of the most recent reporting period, ProText Mobility reported total debt of $191.56K.

How much cash does ProText Mobility have on hand?

ProText Mobility reported $0.00 in cash and cash equivalents in its most recent financial results.

What is ProText Mobility’s dividend yield?

ProText Mobility does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.